![]() |
Magna International Inc. 337 Magna Drive Aurora, Ontario L4G 7K1 Tel (905) 726-2462 Fax (905) 726-7164 |
• |
Evaluated the reasonableness of management’s forecasted revenue and production volumes through consideration of the following: |
○ |
Historical sales volumes; |
○ |
Analyst and industry reports; |
○ |
Pipeline of contracts in the proposal stage; |
○ |
Underlying management analyses detailing growth plans; |
○ |
Known changes in the Company’s operations, which are expected to impact future operating performance; and |
○ |
Internal communications to management and the Board of Directors. |
• |
With the assistance of fair value specialists, evaluated the reasonableness of the discount rate by testing the source information underlying the determination of the discount rate and developing a range of independent estimates and comparing those to the discount rate selected by management. |
• |
With the assistance of fair value specialists, evaluated the reasonableness of the terminal growth rate by developing a range of independent estimates and comparing those to the terminal growth rate selected by management. |
• |
Evaluated the effectiveness of controls over the determination of forecasted sales volumes, discount rates and terminal growth rates. |
Note |
2025 |
2024 | ||||||||||||
| Sales |
$ |
$ | |
|||||||||||
| Costs and expenses |
||||||||||||||
| Cost of goods sold |
||||||||||||||
| Selling, general and administrative |
||||||||||||||
| Depreciation |
||||||||||||||
| Amortization of acquired intangible assets |
||||||||||||||
| Interest expense, net |
17 | |||||||||||||
| Equity income |
( |
) |
( |
) | ||||||||||
| Other expense, net |
4 | |||||||||||||
| Income from operations before income taxes |
||||||||||||||
| Income taxes |
13 | |||||||||||||
| Net income |
||||||||||||||
| Income attributable to non-controlling interests |
( |
) |
( |
) | ||||||||||
| Net income attributable to Magna International Inc. |
$ |
$ | ||||||||||||
| Earnings per Common Share: |
5 | |||||||||||||
| Basic |
$ |
$ | ||||||||||||
| Diluted |
$ |
$ | ||||||||||||
| Weighted average number of Common Shares outstanding during the year [in millions]: |
5 | |||||||||||||
| Basic |
||||||||||||||
| Diluted |
||||||||||||||
Note |
2025 |
2024 | ||||||||||||
Net income |
$ |
$ | |
|||||||||||
Other comprehensive income (loss), net of tax: |
22 | |||||||||||||
Net unrealized gain (loss) on translation of net investment in foreign operations |
( |
) | ||||||||||||
Net unrealized gain (loss) on cash flow hedges |
( |
) | ||||||||||||
Pension and post-retirement benefits |
||||||||||||||
Reclassification of net loss (gain) on cash flow hedges to net income |
( |
) | ||||||||||||
Reclassification of net loss on pensions to net income |
||||||||||||||
Net unrealized gain on available-for-sale |
||||||||||||||
Other comprehensive income (loss) |
( |
) | ||||||||||||
Comprehensive income |
||||||||||||||
Comprehensive income attributable to non-controlling interests |
( |
) |
( |
) | ||||||||||
Comprehensive income attributable to Magna International Inc. |
$ |
$ | ||||||||||||
Note |
2025 |
2024 | ||||||||||||
ASSETS |
||||||||||||||
Current assets |
||||||||||||||
Cash and cash equivalents |
6 | $ |
$ | |||||||||||
Accounts receivable |
||||||||||||||
Inventories |
9 | |||||||||||||
Prepaid expenses and other |
||||||||||||||
Investments |
10 | |||||||||||||
Fixed assets, net |
11 | |||||||||||||
Operating lease right-of-use |
18 | |||||||||||||
Intangible assets, net |
14 | |||||||||||||
Goodwill |
12 | |||||||||||||
Other assets |
15, 19 | |||||||||||||
Deferred tax assets |
13 | |||||||||||||
$ |
$ | |
||||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||||||||
Current liabilities |
||||||||||||||
Short-term borrowing |
$ |
$ | ||||||||||||
Long-term debt due within one year |
17 | |||||||||||||
Accounts payable |
||||||||||||||
Other accrued liabilities |
16 | |||||||||||||
Accrued salaries and wages |
||||||||||||||
Income taxes payable |
||||||||||||||
Current portion of operating lease liabilities |
18 | |||||||||||||
Long-term debt |
17 | |||||||||||||
Operating lease liabilities |
18 | |||||||||||||
Long-term employee benefit liabilities |
19 | |||||||||||||
Other long-term liabilities |
20 | |||||||||||||
Deferred tax liabilities |
13 | |||||||||||||
Shareholders’ equity |
||||||||||||||
Common Shares [issued: 2025 – |
21 | |||||||||||||
Contributed surplus |
||||||||||||||
Retained earnings |
||||||||||||||
Accumulated other comprehensive loss |
22 | ( |
) |
( |
) | |||||||||
Non-controlling interests |
8 | |||||||||||||
$ |
$ | |||||||||||||
On behalf of the Board: |
||||
/s/ “Mary Lou Maher” |
/s/ “Robert F. MacLellan” | |||
Director |
Chairman of the Board | |||
Note |
2025 |
2024 | ||||||||||||
OPERATING ACTIVITIES |
||||||||||||||
Net income |
$ |
$ | ||||||||||||
Items not involving current cash flows |
6 | |||||||||||||
Changes in operating assets and liabilities |
6 | |||||||||||||
Cash provided from operating activities |
||||||||||||||
INVESTMENT ACTIVITIES |
||||||||||||||
Fixed asset additions |
( |
) |
( |
) | ||||||||||
Acquisitions |
7 | ( |
) |
( |
) | |||||||||
Increase in investments, other assets and intangible assets |
( |
) |
( |
) | ||||||||||
Increase in public and private equity investments |
( |
) |
( |
) | ||||||||||
Proceeds from dispositions of fixed assets, other assets and investments |
||||||||||||||
Net cash inflow from disposal of facilities |
4 | |||||||||||||
Cash used for investing activities |
( |
) |
( |
) | ||||||||||
FINANCING ACTIVITIES |
||||||||||||||
Issues of debt |
17 | |||||||||||||
Decrease in short-term borrowings |
( |
) |
( |
) | ||||||||||
Repayments of debt |
17 | ( |
) |
( |
) | |||||||||
Issue of Common Shares on exercise of stock options |
||||||||||||||
Tax withholdings on vesting of equity awards |
( |
) |
( |
) | ||||||||||
Repurchase of Common Shares |
21 | ( |
) |
( |
) | |||||||||
Dividends |
( |
) |
( |
) | ||||||||||
Dividends paid to non-controlling interests |
( |
) |
( |
) | ||||||||||
Acquisition of non-controlling interest |
8 | ( |
) |
|||||||||||
Cash used for financing activities |
( |
) |
( |
) | ||||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) |
( |
) | ||||||||||
Net increase in cash and cash equivalents during the year |
||||||||||||||
Cash and cash equivalents, beginning of year |
||||||||||||||
Cash and cash equivalents, end of year |
6 | $ |
$ | |
||||||||||
Common Shares |
Contri- buted Surplus |
Retained Earnings |
AOCL [i] |
Non- controlling Interests |
Total Equity |
|||||||||||||||||||||||
Number |
Stated Value |
|||||||||||||||||||||||||||
[in millions] |
||||||||||||||||||||||||||||
| Balance, December 31, 2023 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
| Net income |
||||||||||||||||||||||||||||
| Other comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
| Shares issued on exercise of stock options |
( |
) | ||||||||||||||||||||||||||
| Release of stock and stock units |
( |
) | — | |||||||||||||||||||||||||
| Tax withholdings on vesting of equity awards |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Repurchase and cancellation under normal course issuer bids [note 21] |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Stock-based compensation expense |
||||||||||||||||||||||||||||
| Dividends paid to non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
| Dividends paid [$ |
( |
) | ( |
) | ||||||||||||||||||||||||
| Balance, December 31, 2024 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
| Net income |
||||||||||||||||||||||||||||
| Other comprehensive income |
||||||||||||||||||||||||||||
| Shares issued on exercise of stock options |
( |
) | ||||||||||||||||||||||||||
| Release of stock and stock units |
( |
) | — | |||||||||||||||||||||||||
| Tax withholdings on vesting of equity awards |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Repurchase and cancellation under normal course issuer bids [note 21] |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
| Stock-based compensation expense |
||||||||||||||||||||||||||||
| Acquisition of non-controlling interest [note 8] |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
| Dividends paid to non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
| Dividends paid [$ |
( |
) |
( |
) | ||||||||||||||||||||||||
| Balance, December 31, 2025 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
2025 |
2024 | |||||||||
Impairment of assets [a] |
$ |
$ | ||||||||
Restructuring activities [b] |
||||||||||
Investments [c] |
||||||||||
Impacts related to Fisker Inc. [“Fisker”] [d] |
||||||||||
Gain on business combination [e] |
( |
) | ||||||||
Other expense, net |
$ |
$ | |
|||||||
[a] |
Impairment of assets |
[b] |
Restructuring activities |
2025 |
2024 | |||||||||
Complete Vehicles [i] |
$ |
$ | ||||||||
Power & Vision [ii] |
||||||||||
Body Exteriors & Structures [iii] |
||||||||||
Other expense, net |
||||||||||
Tax effect |
( |
) |
( |
) | ||||||
Net loss attributable to Magna |
$ |
$ | |
|||||||
[i] |
During 2025, the Company recorded $ |
[ii] |
During 2025, the Company recorded $ |
[iii] |
During 2025, the Company recorded $ |
[c] |
Investments |
2025 |
2024 | |||||||
Revaluation loss (gain) on public company warrants |
$ |
$ | ( |
) | ||||
Non-cash impairment charge [i] |
||||||||
Net revaluation (gain) loss on public and private equity investments |
( |
) |
||||||
Sales of public equity investments |
( |
) |
||||||
Other expense, net |
||||||||
Tax effect |
||||||||
Net loss attributable to Magna |
$ |
$ | |
|||||
[i] |
The non-cash impairment charge relates to the impairment of a private equity investment. |
[d] |
Impacts related to Fisker |
2025 |
2024 | |||||||
Impairment and supplier related settlements |
$ |
$ | ||||||
Impairment of Fisker warrants |
||||||||
Additional restructuring related to Complete Vehicles |
|
|||||||
Recognition of deferred revenue |
( |
) | ||||||
Other expense, net |
||||||||
Tax effect |
( |
) | ||||||
Net loss attributable to Magna |
$ |
$ | ||||||
[e] |
Gain on business combination |
5. |
EARNINGS PER SHARE |
2025 |
2024 | |||||||
Basic earnings per Common Share: |
||||||||
Net income attributable to Magna International Inc. |
$ |
$ | |
|||||
Weighted average number of Common Shares outstanding during the year |
||||||||
Basic earnings per Common Share |
$ |
$ | ||||||
Diluted earnings per Common Share [a]: |
||||||||
Net income attributable to Magna International Inc. |
$ |
$ | ||||||
Weighted average number of Common Shares outstanding during the year |
||||||||
Stock options and share awards |
||||||||
Diluted earnings per Common Share |
$ |
$ | ||||||
| [a] | Diluted earnings per Common Share exclude two-class method was excluded from the calculation of earnings per share because the effect would be immaterial. |
| [a] | Cash and cash equivalents consist of: |
2025 |
2024 | |||||||||||
Cash |
$ |
$ | ||||||||||
Bank term deposits and bankers’ acceptances |
||||||||||||
$ |
$ | |
||||||||||
| [b] | Items not involving current cash flows: |
2025 |
2024 | |||||||||||
Depreciation |
$ |
$ | ||||||||||
Amortization of acquired intangible assets |
||||||||||||
Amortization of other assets and intangible assets included in cost of goods sold |
||||||||||||
Deferred revenue amortization |
( |
) |
( |
) | ||||||||
Other non-cash charges |
||||||||||||
Deferred tax recovery |
( |
) |
( |
) | ||||||||
Dividends received in excess of equity income |
||||||||||||
Non-cash portion of Other expense, net [note 4] |
||||||||||||
$ |
$ | |
||||||||||
| [c] | Changes in operating assets and liabilities: |
2025 |
2024 | |||||||||||
Accounts receivable |
$ |
$ | ||||||||||
Inventories |
||||||||||||
Prepaid expenses and other |
( |
) | ||||||||||
Accounts payable |
( |
) |
( |
) | ||||||||
Accrued salaries and wages |
( |
) |
||||||||||
Other accrued liabilities |
||||||||||||
Income taxes (receivable) payable |
( |
) |
||||||||||
$ |
$ | |
||||||||||
2025 |
2024 | |||||||||||
Raw materials and supplies |
$ |
$ | ||||||||||
Work-in-process |
||||||||||||
Finished goods |
||||||||||||
Tooling and engineering |
||||||||||||
$ |
$ | |
||||||||||
2025 |
2024 | |||||||||||
Equity method investments [a] |
$ |
$ | ||||||||||
Public and private equity investments [b] |
||||||||||||
Debt investments |
||||||||||||
Warrants |
||||||||||||
$ |
$ | |
||||||||||
| [a] | The ownership percentages and carrying values of the Company’s principal equity method investments at December 31 were as follows [in millions, except percentages]: |
2025 |
2024 |
|||||||||||||||||
LG Magna e-Powertrain Co., Ltd. [i] |
% |
$ |
$ | |
||||||||||||||
Litens Automotive Partnership [ii] |
% |
$ |
$ | |||||||||||||||
Hubei HAPM Magna Seating Systems Co., Ltd. |
% |
$ |
$ | |||||||||||||||
BAIC BluePark Magna Automobile Co., Ltd. |
% |
$ |
$ | |||||||||||||||
[i] |
LG Magna e-Powertrain [“LGM”] is a variable interest entity [‘‘VIE’’] and depends on the Company and LG Electronics for any additional cash needs. The Company cannot make key operating decisions considered the most significant to the VIE, and is therefore not the primary beneficiary. The Company’s known maximum exposure to loss approximated the carrying value of its investment balance as at December 31, 2025. |
[ii] |
The Company accounts for its investments under the equity method of accounting as a result of significant participating rights held by our partner that prevent control. |
2025 |
2024 | |||||||||||
| Current assets |
$ |
$ | |
|||||||||
| Non-current assets |
$ |
$ | ||||||||||
| Current liabilities |
$ |
$ | ||||||||||
| Long-term liabilities |
$ |
$ | ||||||||||
2025 |
2024 | |||||||||||
| Sales |
$ |
$ | |
|||||||||
| Cost of goods sold & expenses |
||||||||||||
| Net income |
$ |
|
|
$ |
|
| ||||||
2025 |
2024 | |||||||||||
| Cost |
||||||||||||
| Land |
$ |
$ | ||||||||||
| Buildings |
||||||||||||
| Machinery and equipment |
|
|||||||||||
| Accumulated depreciation |
||||||||||||
| Buildings |
( |
) |
( |
) | ||||||||
| Machinery and equipment |
( |
) |
( |
) | ||||||||
$ |
$ | |||||||||||
Body Exteriors & Structures |
Power & Vision |
Seating Systems |
Complete Vehicles |
Corporate |
Total |
|||||||||||||||||||
| Balance, December 31, 2023 |
||||||||||||||||||||||||
| Acquisitions |
||||||||||||||||||||||||
| Foreign exchange and other |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Balance, December 31, 2024 |
||||||||||||||||||||||||
| |
— |
( |
) |
— |
— |
— |
( |
) | ||||||||||||||||
| Acquisitions |
||||||||||||||||||||||||
| Foreign exchange and other |
( |
) |
||||||||||||||||||||||
| Balance, December 31, 2025 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
| [a] | Upon adoption of ASU No. 2023-09 described in Note 3, for the year ended December 31, 2025, the provision for income taxes differs from the expense that would be obtained by applying the Canadian federal statutory income tax rate as a result of the following: |
2025 |
||||||||||
Canadian federal income tax rate |
$ |
% | ||||||||
Canada federal |
||||||||||
Effect of cross-border tax laws |
( |
) |
( |
) | ||||||
Other |
( |
) |
( |
) | ||||||
Ontario tax, net of federal effect |
||||||||||
Foreign tax effects |
||||||||||
Mexico |
||||||||||
Statutory tax rate differential |
||||||||||
Tax on distribution of earnings |
||||||||||
Foreign exchange re-measurement |
( |
) |
( |
) | ||||||
Deductible inflationary adjustments |
( |
) |
( |
) | ||||||
Other |
||||||||||
China |
||||||||||
Statutory tax rate differential |
||||||||||
Tax on distribution of earnings |
||||||||||
Tax incentive regimes |
( |
) |
( |
) | ||||||
Research and development tax credits |
( |
) |
( |
) | ||||||
Other |
||||||||||
Sweden |
||||||||||
Non-deductible impairment |
||||||||||
Statutory tax rate differential |
( |
) |
( |
) | ||||||
Other |
||||||||||
United States |
||||||||||
Non-deductible impairment |
||||||||||
Research and development tax credits |
( |
) |
( |
) | ||||||
Other |
( |
) |
( |
) | ||||||
Austria |
||||||||||
Effect of cross-border tax laws |
( |
) |
( |
) | ||||||
Other |
||||||||||
Other foreign jurisdictions |
||||||||||
Changes in unrecognized tax benefits |
( |
) |
( |
) | ||||||
Effective income tax rate |
$ |
% | ||||||||
| 2024 | ||||
Canadian statutory income tax rate |
% | |||
Tax on distribution of foreign earnings |
||||
Valuation allowance on deferred tax assets |
||||
Net effect of losses not benefited |
||||
Foreign exchange re-measurement |
||||
Changes in unrecognized tax benefits |
( |
) | ||
Non-taxable capital gains |
( |
) | ||
Earnings of equity accounted investees |
( |
) | ||
Deductible inflationary adjustments |
( |
) | ||
Foreign rate differentials |
( |
) | ||
Research and development tax credits |
( |
) | ||
Other |
||||
Effective income tax rate |
% | |||
| [b] | The details of income (loss) before income taxes by jurisdiction are as follows: |
2025 |
2024 [i] |
|||||||||
Canadian |
$ |
$ | ||||||||
Foreign |
||||||||||
$ |
$ | |
||||||||
[i] |
Certain amounts in the prior period have been reclassified to conform with current period presentation. |
| [c] | The details of the income tax provision are as follows: |
2025 |
2024 [i] |
|||||||||
Current |
||||||||||
Canadian federal |
$ |
$ | ||||||||
Canadian provincial (Ontario) |
||||||||||
Foreign |
||||||||||
Deferred |
||||||||||
Canadian federal |
( |
) |
( |
) | ||||||
Canadian provincial (Ontario) |
( |
) |
( |
) | ||||||
Foreign |
( |
) |
( |
) | ||||||
( |
) |
( |
) | |||||||
$ |
$ | |
||||||||
[i] |
Certain amounts in the prior period have been reclassified to conform with current period presentation. |
| [d] | Deferred income taxes have been provided on temporary differences, which consist of the following: |
2025 |
2024 | |||||||
Net decrease (increase) in non-deductible liabilities |
$ |
$ | ( |
) | ||||
Tax on undistributed foreign earnings |
||||||||
Change in valuation allowance on deferred tax assets |
||||||||
Unrealized remeasurement of investments |
( |
) |
|
|||||
Net tax losses benefit |
( |
) |
( |
) | ||||
Tax depreciation (less than) in excess of book depreciation |
( |
) |
||||||
Book amortization in excess of tax amortization |
( |
) |
( |
) | ||||
Other |
||||||||
$ |
( |
) |
$ | ( |
) | |||
| [e] | Deferred tax assets and liabilities consist of the following temporary differences: |
2025 |
2024 | |||||||||
Assets |
||||||||||
| Tax benefit of loss carryforwards | $ |
$ | ||||||||
| Liabilities currently not deductible for tax | ||||||||||
| Operating lease liabilities | ||||||||||
| Other assets tax value in excess of book value | |
|||||||||
| Unrealized losses on foreign exchange hedges and retirement liabilities | ||||||||||
| Tax credit carryforwards | ||||||||||
| Unrealized losses on remeasurement of investments | ||||||||||
| Other | ||||||||||
Valuation allowance against tax benefit of loss carryforwards |
( |
) |
( |
) | ||||||
Other valuation allowance |
( |
) |
( |
) | ||||||
$ |
$ | |
||||||||
Liabilities |
||||||||||
Operating lease right-of-use |
||||||||||
Tax depreciation in excess of book depreciation |
||||||||||
Tax on undistributed foreign earnings |
||||||||||
Unrealized gain on foreign exchange hedges and retirement liabilities |
||||||||||
Net deferred tax assets |
$ |
$ | ||||||||
2025 |
2024 | |||||||
Long-term deferred tax assets |
$ |
$ | ||||||
Long-term deferred tax liabilities |
( |
) |
( |
) | ||||
$ |
$ | |
||||||
| [f] | Deferred income taxes have not been provided on undistributed earnings of certain foreign subsidiaries, as the Company has concluded that such earnings should not give rise to additional tax liabilities upon repatriation or are indefinitely reinvested. A determination of the amount of the unrecognized tax liability relating to the remittance of such undistributed earnings is not practicable. |
| [g] | Income taxes paid in cash [net of refunds] for the year ended December 31, 2025 were $ |
2025 |
2024 | |||||||||||
Canadian federal |
$ |
$ | ||||||||||
Canadian provincial (Ontario) |
||||||||||||
Foreign |
||||||||||||
Mexico |
||||||||||||
China |
||||||||||||
United States |
||||||||||||
Germany |
||||||||||||
Austria |
( |
) | ||||||||||
Other |
||||||||||||
$ |
$ | |
||||||||||
| [h] | As at December 31, 2025, the Company had domestic and foreign operating loss carryforwards of $ |
| [i] | As at December 31, 2025 and 2024, the Company’s gross unrecognized tax benefits were $ |
2025 |
2024 | |||||||||||
Balance, beginning of year |
$ |
$ | ||||||||||
Increase based on tax positions related to current year |
||||||||||||
Increase based on tax positions of prior years |
||||||||||||
Settlements |
( |
) |
( |
) | ||||||||
Foreign currency translation |
( |
) | ||||||||||
Statute expirations |
( |
) |
( |
) | ||||||||
$ |
$ | |
||||||||||
Remaining weighted average useful life in years |
2025 |
2024 |
||||||||||
Cost |
||||||||||||
Customer relationship intangibles |
$ |
$ |
||||||||||
Patents and technology |
||||||||||||
Computer software and other licenses |
||||||||||||
Accumulated depreciation |
||||||||||||
Customer relationship intangibles |
( |
) |
( |
) | ||||||||
Patents and technology |
( |
) |
( |
) | ||||||||
Computer software and other licenses |
( |
) |
( |
) | ||||||||
$ |
$ |
|||||||||||
2025 |
2024 |
|||||||
Preproduction costs related to long-term supply agreements |
$ |
$ |
||||||
Long-term receivables [i] |
||||||||
Pension overfunded status [note 19[a]] |
||||||||
Unrealized gain on cash flow hedges [note 23] |
||||||||
Other, net [i] |
||||||||
$ |
$ |
|||||||
2025 |
2024 |
|||||||
Balance, beginning of year |
$ |
$ | ||||||
Expense, net |
||||||||
Settlements |
( |
) |
( |
) | ||||
Foreign exchange and other |
( |
) | ||||||
$ |
$ | |
||||||
[a] |
Commercial Paper Program |
[b] |
Credit Facilities |
| [a] | The Company’s long-term debt, net of unamortized issuance costs, is substantially uncollateralized and consists of the following: |
2025 |
2024 | |||||||
Senior Notes [i] |
||||||||
€ |
$ |
$ | ||||||
$ |
||||||||
Cdn$ |
||||||||
$ |
||||||||
Cdn$ |
||||||||
€ |
— | |||||||
€ |
||||||||
$ |
||||||||
$ |
— | |||||||
$ |
— |
|||||||
$ |
— |
|||||||
Bank term debt at a weighted average interest rate of |
||||||||
Government loans at a weighted average interest rate of |
||||||||
Other |
||||||||
Less due within one year |
||||||||
$ |
$ |
|||||||
[i] |
The Senior Notes are unsecured obligations and do not include any financial covenants. The Company may redeem the notes in whole or in part at any time, and from time to time, at specified redemption prices determined in accordance with the terms of the indenture governing the Senior Notes. |
| [b] | Future principal repayments on long-term debt are estimated to be as follows: |
2026 |
$ |
|||
2027 |
||||
2028 |
||||
2029 |
||||
2030 |
||||
Thereafter |
||||
$ |
||||
| [c] | The Company issued the following Senior Notes during 2025: |
Settlement Date |
Net Cash Proceeds [i] |
Maturity Date | ||||
€ |
€ |
|||||
$ |
$ |
|||||
[i] |
Net cash proceeds represent the public offering price less the underwriting discount, before expenses. |
| [d] | On March 21, 2025, the Company extended the maturity date of its $ |
| [e] | The Company had a syndicated, unsecured, delayed draw term loan facility [the “Term Loan”] consisting of a 3-year tranche of $5-year tranche of $3-year delayed draw tranche of $ |
| [f] | Interest expense, net includes: |
2025 |
2024 | |||||||||
Interest expense |
||||||||||
Current |
$ |
$ | ||||||||
Long-term |
||||||||||
Interest income |
( |
) |
( |
) | ||||||
Interest expense, net |
$ |
$ |
|
| ||||||
| [g] | Interest paid in cash was $ |
| [a] | The Company has entered into leases primarily for real estate, manufacturing equipment, and vehicles with terms that typically range from |
2025 |
2024 | |||||||
Operating lease expense |
$ |
$ | ||||||
Short-term lease expense |
||||||||
Variable lease expense |
||||||||
Total lease expense |
$ |
$ |
||||||
2025 |
2024 | |||||||
Operating cash flows – cash paid |
$ |
$ | ||||||
New right-of-use |
$ |
$ | ||||||
Weighted-average remaining lease term |
|
|||||||
Weighted-average discount rate |
||||||||
| [b] | Operating lease liabilities consist of: |
Current operating liabilities |
$ |
$ | ||||||
Non-current operating lease liabilities |
||||||||
Total lease liabilities |
$ |
$ |
| [c] | Future annual payments for operating leases are as follows [i]: |
2025 [i] |
||||
2026 |
$ |
|||
2027 |
||||
2028 |
||||
2029 |
||||
2030 |
||||
Thereafter |
||||
Less: amount representing interest |
||||
Total lease liabilities |
$ |
|||
[i] |
Excludes $ |
| [d] | The Company’s finance leases were not material for any of the periods presented. |
2025 |
2024 | |||||||
Defined benefit pension plans and other [a] |
$ |
$ | ||||||
Termination and long-term service arrangements [b] |
||||||||
Retirement medical benefits plans |
||||||||
Other long-term employee benefits |
||||||||
Long-term employee benefit obligations |
$ |
$ |
||||||
[a] |
Defined benefit pension plans |
2025 |
2024 | |||||||
Projected benefit obligation |
||||||||
Discount rate |
% |
|||||||
Rate of compensation increase |
% |
|||||||
Net periodic benefit cost |
||||||||
Discount rate |
% |
|||||||
Rate of compensation increase |
% |
|||||||
Expected return on plan assets |
% |
|||||||
2025 |
2024 | |||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ | ||||||
Current service cost |
||||||||
Interest cost |
||||||||
Actuarial gains and changes in actuarial assumptions |
( |
) |
( |
) | ||||
Benefits paid |
( |
) |
( |
) | ||||
Divestiture |
( |
) |
||||||
Foreign exchange |
( |
) | ||||||
End of year |
||||||||
Plan assets at fair value [i] |
||||||||
Beginning of year |
||||||||
Return on plan assets |
||||||||
Employer contributions |
||||||||
Benefits paid |
( |
) |
( |
) | ||||
Foreign exchange |
( |
) | ||||||
End of year |
||||||||
Ending funded status – Plan deficit |
$ |
$ | ||||||
Amounts recorded in the consolidated balance sheet |
||||||||
Non-current asset [note 15] |
$ |
$ | ||||||
Current liability |
||||||||
Non-current liability |
||||||||
Net liability |
$ |
$ | ||||||
Unrecognized actuarial losses recorded in accumulated other comprehensive income |
$ |
( |
) |
$ | ( |
) | ||
| Net periodic benefit cost |
||||||||
| Current service cost |
$ |
$ | ||||||
| Interest cost |
||||||||
| Return on plan assets |
( |
) |
( |
) | ||||
| Actuarial losses (gains) |
( |
) | ||||||
| Net periodic benefit cost |
$ |
$ | ( |
) | ||||
[i] |
The asset allocation of the Company’s defined benefit pension plans at December 31, 2025 and the target allocation range for 2026 are as follows: |
2026 |
2025 | |||||||
| Fixed income securities |
||||||||
| Equity securities |
||||||||
| Cash and cash equivalents |
||||||||
[b] |
Termination and long-term service arrangements |
2025 |
2024 | |||||||
| Discount rate |
||||||||
| Rate of compensation increase |
||||||||
2025 |
2024 |
|||||||
| Projected benefit obligation |
||||||||
| Beginning of year |
$ |
$ | ||||||
| Current service cost |
||||||||
| Interest cost |
||||||||
| Actuarial gains and changes in actuarial assumptions |
( |
) |
( |
) | ||||
| Benefits paid |
( |
) |
( |
) | ||||
| Foreign exchange |
( |
) | ||||||
| Ending funded status – Plan deficit |
$ |
$ | |
|||||
| Amounts recorded in the consolidated balance sheet |
||||||||
| Current liability |
$ |
$ | ||||||
| Non-current liability |
||||||||
| Net liability |
$ |
$ | ||||||
| Unrecognized actuarial losses recorded in accumulated other comprehensive income |
$ |
( |
) |
$ | ( |
) | ||
| Net periodic benefit cost |
||||||||
| Current service cost |
$ |
$ | ||||||
| Interest cost |
||||||||
| Actuarial (gains) losses |
( |
) |
||||||
| Net periodic benefit cost |
$ |
$ | ||||||
[c] |
Future benefit payments |
Defined benefit pension plans |
Termination and long-term service arrangements |
Retirement medical benefits plans |
Total |
|||||||||||||
| Expected employer contributions - 2026 |
$ | $ | $ | $ | ||||||||||||
| Expected benefit payments: |
||||||||||||||||
| 2026 |
$ | $ | $ | $ | ||||||||||||
| 2027 |
||||||||||||||||
| 2028 |
||||||||||||||||
| 2029 |
||||||||||||||||
| 2030 |
||||||||||||||||
| Thereafter |
||||||||||||||||
| $ | $ | $ | |
$ | |
|||||||||||
2025 |
2024 |
|||||||
| Long-term portion of deferred revenue |
$ |
$ | |
|||||
| Long-term portion of income taxes payable |
||||||||
| Asset retirement obligation |
||||||||
| Long-term portion of fair value of hedges [note 23] |
||||||||
| Other |
||||||||
$ |
$ | |||||||
| [a] | At December 31, 2025, the Company’s authorized, issued and outstanding capital stock are as follows: |
| [i] | Each share is entitled to |
| [ii] | Each share shall participate equally as to dividends. |
| [b] | The Company had a normal course issuer bid in place for the 12-month period ending February 2025 [“Prior 2024 Bid”], which was terminated on November 6, 2024. Subsequently, the Company entered into a normal course issuer bid for the 12-month period ending November 2025 [“2024 Bid”], which was terminated on November 6, 2025. |
2025 |
2024 | |||||||||||||||||||
Shares purchased |
Cash amount |
Shares purchased |
Cash amount |
|||||||||||||||||
Prior 2024 Bid |
$ |
$ |
||||||||||||||||||
2024 Bid |
||||||||||||||||||||
2025 Bid |
||||||||||||||||||||
$ |
$ |
|||||||||||||||||||
| [c] | The following table presents the maximum number of shares that would be outstanding if all the dilutive instruments outstanding at February 25, 2026 were exercised or converted: |
Common Shares |
||||
Stock options [i] and share awards |
||||
[i] |
Options to purchase Common Shares are exercisable by the holder in accordance with the vesting provisions and upon payment of the exercise price as may be determined from time to time pursuant to the Company’s stock option plans. |
2025 |
2024 | |||||||
Accumulated net unrealized loss on translation of net investment in foreign operations |
||||||||
Balance, beginning of year |
$ |
( |
) |
$ | ( |
) | ||
Net unrealized gain (loss) |
( |
) | ||||||
Repurchase of shares under Normal Course Issuer Bids [note 21] |
||||||||
Balance, end of year |
( |
) |
( |
) | ||||
Accumulated net unrealized gain on cash flow hedges [b] |
||||||||
Balance, beginning of year |
( |
) |
||||||
Net unrealized gain (loss) |
( |
) | ||||||
Reclassifications to net income [a] |
( |
) | ||||||
Balance, end of year |
( |
) | ||||||
Accumulated net unrealized loss on other long-term employee benefit liabilities [b] |
||||||||
Balance, beginning of year |
( |
) |
( |
) | ||||
Revaluation |
||||||||
Reclassifications to net income [a] |
||||||||
Balance, end of year |
( |
) |
( |
) | ||||
Accumulated net unrealized gain on available-for-sale |
||||||||
Balance, beginning of year |
||||||||
Revaluation |
||||||||
Balance, end of year |
||||||||
Total accumulated other comprehensive loss [c] |
$ |
( |
) |
$ | ( |
) | ||
| [a] | The effects on net income of amounts reclassified from AOCL were as follows: |
2025 |
2024 | |||||||
Cash flow hedges |
||||||||
Sales |
$ |
( |
) |
$ | ( |
|||
Cost of sales |
||||||||
Income tax |
( |
) | ||||||
Net of tax |
( |
) |
||||||
Other long-term employee benefit liabilities |
||||||||
Cost of sales |
( |
) |
( |
) | ||||
Income tax |
||||||||
Net of tax |
( |
) |
( |
) | ||||
Total reclassification to net income |
$ |
( |
) |
$ | ||||
| [b] | The amount of income tax (loss) benefit that has been allocated to each component of other comprehensive loss is as follows: |
2025 |
2024 | |||||||
Accumulated net unrealized loss on translation of net investment in foreign operations |
$ |
$ | ||||||
Accumulated net unrealized gain on cash flow hedges |
||||||||
Balance, beginning of year |
( |
) | ||||||
Net unrealized (loss) gain |
( |
) |
||||||
Reclassifications to net income |
( |
) |
||||||
Balance, end of year |
( |
) |
||||||
Accumulated net unrealized loss on other long-term liabilities |
||||||||
Balance, beginning of year |
||||||||
Net unrealized loss |
( |
) |
( |
) | ||||
Reclassifications to net income |
( |
) |
( |
) | ||||
Balance, end of year |
||||||||
Total income tax (loss) benefit |
$ |
( |
) |
$ | ||||
| [c] | The amount of other comprehensive gain that is expected to be reclassified to net income during 2026 is $ |
[a] |
Foreign exchange contracts |
| For Canadian dollars | For U.S dollars | For euros | ||||||||||||||||||||||||||||||||||||||
Buy (sell) |
US dollar amount |
Weighted average rate |
Mexican peso amount |
Weighted average rate |
US dollar amount |
Weighted average rate |
Czech koruna amount |
Weighted average rate |
Swedish kronas amount |
Weighted average rate |
||||||||||||||||||||||||||||||
2026 |
||||||||||||||||||||||||||||||||||||||||
2026 |
( |
) | ( |
) | ( |
) | — | — | — | — | ||||||||||||||||||||||||||||||
2027 |
||||||||||||||||||||||||||||||||||||||||
2027 |
( |
) | ( |
) | ( |
) | — | — | — | — | ||||||||||||||||||||||||||||||
2028 |
||||||||||||||||||||||||||||||||||||||||
2028 |
( |
) | — | — | ( |
) | — | — | — | — | ||||||||||||||||||||||||||||||
2029 |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
2029 |
— | — | — | — | ( |
) | — | — | — | — | ||||||||||||||||||||||||||||||
| ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
[b] |
Financial assets and liabilities |
2025 |
2024 | |||||||
Financial assets |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Accounts receivable |
||||||||
Warrants and public and private equity investments |
||||||||
Debt investments |
||||||||
Long-term receivables included in other assets [note 15] |
||||||||
$ |
$ |
|||||||
Financial liabilities |
||||||||
Short-term borrowing |
$ |
$ |
||||||
Long-term debt (including current portion) |
||||||||
Operating lease liability (including current portion) |
||||||||
Accounts payable |
||||||||
$ |
$ |
|||||||
Foreign currency contracts designated as effective hedges, measured at fair value |
||||||||
Prepaid expenses |
$ |
$ |
||||||
Other assets |
||||||||
Other accrued liabilities |
( |
( |
||||||
Other long-term liabilities |
( |
( |
||||||
$ |
$ ( |
|||||||
[c] |
Derivatives designated as effective hedges, measured at fair value |
Gross amounts presented in consolidated balance sheets |
Gross amounts not offset in consolidated balance sheets |
Net amounts |
||||||||||
December 31, 2025 |
||||||||||||
$ |
$ |
$ |
||||||||||
$ ( |
) |
$ ( |
) |
$ ( |
) | |||||||
December 31, 2024 |
||||||||||||
| $ |
$ |
$ |
||||||||||
| $ ( |
) | $ ( |
) | $ ( |
) | |||||||
[d] |
Supplier financing programs |
2025 |
2024 |
|||||||
Balance, beginning of year |
$ |
$ | ||||||
Amounts settled |
( |
) |
( |
) | ||||
Amounts added to the program |
||||||||
Balance, end of year |
$ |
$ | ||||||
[e] |
Fair value |
[f] |
Credit risk |
[g] |
Currency risk |
[h] |
Interest rate risk |
[i] |
Equity price risk |
| [a] | The following tables show segment information for the Company’s reporting segments and a reconciliation of Adjusted EBIT to the Company’s consolidated income before income taxes: |
| 2025 |
||||||||||||||||||||||
| Total sales |
External sales |
Adjusted EBIT |
Depreciation |
Equity income |
||||||||||||||||||
| Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ ( |
) | ||||||||||||||||
| Power & Vision |
( |
) | ||||||||||||||||||||
| Seating Systems |
( |
) | ||||||||||||||||||||
| Complete Vehicles |
( |
) | ||||||||||||||||||||
| Corporate & Other [i] |
( |
) |
( |
) |
( |
) | ||||||||||||||||
| Total Reportable Segments |
$ |
$ |
$ |
$ |
$ ( |
) | ||||||||||||||||
| 2024 |
||||||||||||||||||||||
| Total sales |
External sales |
Adjusted EBIT |
Depreciation | Equity (income) loss |
||||||||||||||||||
| Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ ( |
) | ||||||||||||||||
| Power & Vision |
( |
) | ||||||||||||||||||||
| Seating Systems |
( |
) | ||||||||||||||||||||
| Complete Vehicles |
( |
) | ||||||||||||||||||||
| Corporate & Other [i] |
( |
) | ( |
) | ||||||||||||||||||
| Total Reportable Segments |
$ |
$ |
$ |
$ |
$ ( |
) | ||||||||||||||||
| 2025 |
||||||||||||||||||||||
| Net assets |
Investments |
Goodwill |
Fixed assets, net |
Fixed asset additions |
||||||||||||||||||
| Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
| Power & Vision |
||||||||||||||||||||||
| Seating Systems |
||||||||||||||||||||||
| Complete Vehicles |
||||||||||||||||||||||
| Corporate & Other |
||||||||||||||||||||||
| Total Reportable Segments |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
2024 |
||||||||||||||||||||||
| Net assets |
Investments | Goodwill | Fixed assets, net |
Fixed asset additions |
||||||||||||||||||
Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
Power & Vision |
||||||||||||||||||||||
Seating Systems |
||||||||||||||||||||||
Complete Vehicles |
||||||||||||||||||||||
Corporate & Other |
||||||||||||||||||||||
Total Reportable Segments |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
[i] |
Included in Corporate and Other Adjusted EBIT are intercompany fees charged to the automotive segments. |
| [b] | The following table reconciles Net income from operations to Adjusted EBIT: |
2025 |
2024 |
|||||||
Net income |
$ |
$ |
||||||
Add: |
||||||||
Amortization of acquired intangible assets |
||||||||
Interest expense, net |
||||||||
Other expense, net |
||||||||
Income taxes |
||||||||
Adjusted EBIT |
$ |
$ |
||||||
| [c] | The following table reconciles Total Assets to Net Assets: |
2025 |
2024 |
|||||||
Total Assets |
$ |
$ |
||||||
Deduct assets not included in segment net assets: |
||||||||
Cash and cash equivalents |
( |
( |
||||||
Deferred tax assets |
( |
( |
||||||
Long-term receivables from joint venture partners |
( |
( |
||||||
Deduct liabilities included in segment net assets: |
||||||||
Accounts payable |
( |
( |
||||||
Accrued salaries and wages |
( |
( |
||||||
Other accrued liabilities |
( |
( |
||||||
Segment Net Assets |
$ |
$ |
||||||
| [d] | The following table aggregates external revenues by customer as follows: |
2025 |
2024 |
|||||||
General Motors |
$ |
$ |
||||||
Daimler AG |
||||||||
Ford Motor Company |
||||||||
BMW |
||||||||
Volkswagen |
||||||||
Stellantis |
||||||||
Other |
||||||||
$ |
$ |
|||||||
| [e] | The following table summarizes external revenues and long-lived assets by geographic region: |
External Sales |
Fixed Assets, Net |
|||||||||||||||
2025 |
2024 | 2025 |
2024 | |||||||||||||
North America |
||||||||||||||||
United States |
$ |
$ |
$ |
$ |
||||||||||||
Mexico |
||||||||||||||||
Canada |
||||||||||||||||
Europe |
||||||||||||||||
Austria |
||||||||||||||||
Germany |
||||||||||||||||
Czech Republic |
||||||||||||||||
Poland |
||||||||||||||||
Spain |
||||||||||||||||
Sweden |
||||||||||||||||
Italy |
||||||||||||||||
United Kingdom |
||||||||||||||||
Turkey |
||||||||||||||||
Slovakia |
||||||||||||||||
France |
||||||||||||||||
Other Europe |
||||||||||||||||
Asia Pacific |
||||||||||||||||
China |
||||||||||||||||
Japan |
||||||||||||||||
India |
||||||||||||||||
Other Asia Pacific |
||||||||||||||||
Rest of World |
||||||||||||||||
Brazil |
||||||||||||||||
Argentina |
||||||||||||||||
Other Rest of World |
||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||